nivolumab,ipilimumab,cabozantinib
bms
['nivolumab', 'pcsm', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'blcsm', 'ipilimumab', 'kcsm,(-skcsm)', 'nivo', 'cosmic-313']
we got an update from on the phase iii cosmic-313 trial evaluating cabozantinib + nivolumab + ipilimumab in 1l advanced rcc of imdc intermediate or poor risk check out for more from #gu23! #pcsm #blcsm #kcsm #tscsm #uroonc 
The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm